Skip to main content

Table 3 Total cost of cancer during the first 12-months post-diagnosis by cancer type1

From: Correction to: CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients

  

COST TO THE AUSTRALIAN HEALTHCARE SYSTEM (AUD)

Patient co-payment5 (AUD)

N2

Hospital episodes3

ED presentations

MBS rebate4

PBS rebate

Total cost to the healthcare system

Average healthcare cost per person (SD)

Total

Average per person (SD)

All cancers combined

123,900

3,824,163,400

88,103,100

263,243,600

631,804,300

4,807,314,400

38,800 (42,900)

127,673,700

1000 (2000)

Prostate cancer

20,700

374,172,600

6,416,200

36,828, 600

38,650,600

456,068,000

22,000 (18,700)

16,324,000

800 (1200)

Breast cancer

15,400

377,396,200

6,744,700

36,690, 600

170,956,200

591,787,700

38,300 (31,300)

21,040, 900

1400 (1500)

Colorectal cancer

14,800

643,503,400

11,849,400

30,563,000

71,878,900

757,794,700

51,300 (39,800)

16,979,500

1100 (1800)

Blood and lymphatic system

13,300

616,132,000

13,286,600

40,503,100

176,947,100

846,868,700

63,600 (73,600)

24,655,400

1900 (4100)

Melanoma of the skin

12,300

70,844,800

1,575,700

23,174,800

12,506,700

108,102,000

8800 (13,400)

4,945,100

400 (500)

Tracheal, bronchus and lung cancer

11,100

434,675,600

15,618,400

24,164,600

45,331,000

519,789,700

46,800 (35,700)

10,168,700

900 (1700)

Digestive organs

10,100

433,725,600

12,668,100

20,303,100

31,119,600

497,816,400

49,400 (38,400)

11,273,000

1100 (2000)

Cancers of the urinary tract

6200

202,334,900

5,022,300

10,703,000

17,623,000

235,683,200

38,000 (32,600)

4,816,000

800 (1100)

Gynaecological cancers

5200

159,616,700

3,121,600

10,475,000

16,774,700

189,988,000

36,400 (32,700)

5,171,800

1000 (1600)

Head and neck

4000

141,306,700

2,478,200

10,264,700

9,019,700

163,069,400

40,500 (47,200)

2,374,400

600 (1200)

Other or ill-defined cancers

2700

76,240,900

2,316,900

4,295,300

6,051,400

88,904,500

32,800 (31,500)

2,239,700

800 (1700)

Thyroid and other endocrine glands

2600

55,221,900

799,400

4,195,500

3,631,300

63,848,200

24,600 (35,800)

1,180,600

500 (600)

Eye, brain and CNS

1900

114,903,700

3,113,900

3,324,700

17,342,800

138,685,000

71,800 (73,200)

2,830,000

1500 (2300)

Mesothelioma, Kaposi Sarcoma, and soft tissue

1600

69,741,200

1,882,200

3,245,200

9,187,200

84,055,900

51,500 (47,800)

2,080,100

1300 (2200)

Male genital organs, exc prostate

900

19,635,700

678,900

2,190,200

2,267,400

24,772,300

26,800 (30,900)

643,200

700 (1200)

Other skin cancer

800

15,355,100

283,300

1,749,400

1,456,800

18,844,600

22,700 (30,200)

541,900

700 (1100)

  1. 1Weighted results reported, and rounded to the nearest 100
  2. 2Excluding broad cancer types with less than 500 individuals (‘bone’, and ‘other thoracic and respiratory organs’)
  3. 3Admitted and non-admitted hospital episodes
  4. 4MBS rebate, excluding items included as non-admitted hospital episodes
  5. 5MBS and PBS patient co-payment